Dysport and Jeuveau both compete with Botox, but they do it on different terms — and for an owner, comparing them is about fit and cost, not a clinical leaderboard.
This is general education for owners, not medical advice.
Injectables
Dysport vs Jeuveau: Two Neurotoxin Alternatives in Different Lanes
Both compete with Botox, but on different terms — diffusion profile versus value positioning. The owner's comparison is about fit and cost, not a clinical leaderboard.
1-YEAR MOVE
EOLS
▼15.6%
| Ticker | Company | 1-year change |
|---|---|---|
| EOLS | Evolus | −15.6% |